Legend Biotech to Host Investor Conference Call on Fourth Quarter and Full Year 2023 Results

Rhea-AI Summary

Legend Biotech Corporation (LEGN) will host a conference call to review fourth-quarter and full-year 2023 results. Executive members will discuss the company's performance during the call.

SOMERSET, N.J.--(BUSINESS WIRE)-- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global biotechnology company developing, manufacturing, and commercializing novel therapies to treat life-threatening diseases, will host a conference call for investors at 8:00 am ET on Monday, March 11, 2024, to review fourth-quarter and full-year 2023 results.

During the webcast and conference call, executive members will provide an overview of Legend Biotech’s performance for the quarter and the fiscal year.

Investors and other interested parties may join the live audio webcast of the call via this weblink.

A replay version of the webcast and earnings news release will be available through the Investor Relations section of Legend Biotech’s website under the Events and Presentation section approximately two hours after the call concludes.

ABOUT LEGEND BIOTECH

Legend Biotech is a global biotechnology company dedicated to treating, and one day curing, life-threatening diseases. Headquartered in Somerset, New Jersey, we are developing advanced cell therapies across a diverse array of technology platforms, including autologous and allogeneic chimeric antigen receptor T-cell, gamma-delta T cell (gd T) and natural killer (NK) cell-based immunotherapy. From our three R&D sites around the world, we apply these innovative technologies to pursue the discovery of cutting-edge therapeutics for patients worldwide.

Learn more at www.legendbiotech.com and follow us on X (formerly Twitter) and LinkedIn.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240213850036/en/

INVESTOR:



Jessie Yeung

Tel: (732) 956-8271

jessie.yeung@legendbiotech.com

PRESS:



Alexandra Ventura

Tel: (732) 850-5598

media@legendbiotech.com

Source: Legend Biotech Corporation

FAQ

When will Legend Biotech host a conference call to review fourth-quarter and full-year 2023 results?

Legend Biotech will host a conference call at 8:00 am ET on Monday, March 11, 2024.

Where can investors join the live audio webcast of the call?

Investors can join the live audio webcast of the call via the weblink provided by Legend Biotech.

Where can interested parties find the replay version of the webcast and earnings news release?

Interested parties can find the replay version of the webcast and earnings news release in the Investor Relations section of Legend Biotech's website under the Events and Presentation section.